New Insights Into the Comorbidity of Coronary Heart Disease and Depression

被引:48
作者
Wu, Yeshun
Zhu, Bin
Chen, Zijun
Duan, Jiahao
Luo, Ailin
Yang, Ling
Yang, Chun
机构
基金
中国国家自然科学基金;
关键词
ACUTE MYOCARDIAL-INFARCTION; C-REACTIVE PROTEIN; GROWTH-FACTOR; 21; CARDIOVASCULAR-DISEASE; GUT-MICROBIOTA; NEUROTROPHIC FACTOR; MAJOR DEPRESSION; RATE-VARIABILITY; SEROTONIN TRANSPORTER; MEDICATION ADHERENCE;
D O I
10.1016/j.cpcardiol.2019.03.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronary heart disease (CHD) and depression are common disorders that markedly impair quality of life and impose a great financial burden on society. They are also frequently comorbid, exacerbating patient condition, and worsening prognosis. This comorbidity strongly suggests shared pathologic mechanisms. This review focuses on the incidence of depression in patients with CHD, deleterious effects of depression on CHD symptoms, and the potential mechanisms underlying comorbidity. In addition to the existing frequent mechanisms that are well known for decades, this review summarized interesting and original potential mechanisms to underlie the comorbidity, such as endocrine substances, gut microbiome, and microRNA. Finally, there are several treatment strategies for the comorbidity, involving drugs and psychotherapy, which may provide a theoretical basis for further basic research and clinical investigations on improved therapeutic interventions.
引用
收藏
页数:31
相关论文
共 50 条
  • [21] The Impact of Depression in Heart Disease
    Sher, Yelizaveta
    Lolak, Sermsak
    Maldonado, Jose R.
    CURRENT PSYCHIATRY REPORTS, 2010, 12 (03) : 255 - 264
  • [22] Inflammation, Heart Disease, and Depression
    Halaris, Angelos
    CURRENT PSYCHIATRY REPORTS, 2013, 15 (10)
  • [23] Stress, depression, and coronary artery disease: Modeling comorbidity in female primates
    Shively, Carol A.
    Musselman, Dominique L.
    Willard, Stephanie L.
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2009, 33 (02) : 133 - 144
  • [24] Meta-analysis on inflammation and autonomic nervous system of coronary heart disease combined with depression
    Li, Guo
    Zhang, Lijun
    Liu, Meiyan
    BMJ OPEN, 2024, 14 (03):
  • [25] Symptoms that remain after depression treatment in patients with coronary heart disease
    Carney, Robert M.
    Freedland, Kenneth E.
    Steinmeyer, Brian C.
    Rich, Michael W.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2023, 165
  • [26] Review of major measuring instruments in comorbid depression and coronary heart disease
    Vieweg, W. Victor R.
    Hasnain, Mehrul
    Lesnefsky, Edward J.
    Pandurangi, Ananda K.
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (04) : 905 - 912
  • [27] Depression and Whole Blood Serotonin in Patients With Coronary Heart Disease From the Heart and Soul Study
    Wulsin, Lawson R.
    Musselman, Dominique
    Otte, Christian
    Bruce, Erica
    Ali, Sadia
    Whooley, Mary A.
    PSYCHOSOMATIC MEDICINE, 2009, 71 (03): : 260 - 265
  • [28] Management of depression in patients with coronary heart disease: association, mechanisms, and treatment implications for depressed cardiac patients
    Wang, Jenny T.
    Hoffman, Benson
    Blumenthal, James A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (01) : 85 - 98
  • [29] Depression: a predictor of coronary heart disease in Saudi Arabia
    Alshahrani, S.
    Korairi, H.
    Sharifi, A. Y.
    Alqahtani, M. A. M.
    Al Qahtani, S. A.
    Ahamed, K. M. A.
    Kaabi, A.
    Alzahrani, O. M.
    Abouelyazid, A. Y.
    CARDIOMETRY, 2022, (22): : 147 - 153
  • [30] Mediation of the association between depression and coronary heart disease by metabolic syndrome components
    Smith, Meghan L.
    Gelaye, Bizu
    Tsai, Alexander C.
    Gradus, Jaimie L.
    ANNALS OF EPIDEMIOLOGY, 2024, 92 : 1 - 7